Showing results (51-60 of 85) with videos related to
Sort By:
Pageof 9
International Journal of Molecular Sciences|July 24, 2021
Tumor Escape Phenotype in Bladder Cancer Is Associated with Loss of HLA Class I Expression, T-Cell Exclusion and Stromal ChangesHernani Gil-Julio, Francisco Perea, Antonio Rodriguez-Nicolas, et al.Plos One|July 23, 2013
HLA alleles influence the clinical signature of amoxicillin-clavulanate hepatotoxicityCamilla Stephens, Miguel-Ángel López-Nevot, Francisco Ruiz-Cabello, et al.Annals of Surgical Oncology|April 24, 2019
A Combination of Positive Tumor HLA-I and Negative PD-L1 Expression Provides an Immune Rejection Mechanism in Bladder CancerJosé Francisco Flores-Martín, Francisco Perea, Manuela Exposito-Ruiz, et al.International Journal of Cancer|June 21, 2013
Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanomaAna B del Campo, Jon Amund Kyte, Javier Carretero, et al.International Journal of Legal Medicine|December 6, 2005
Study of six X-linked tetranucleotide microsatellites: population data from five Spanish regionsMaria T Zarrabeitia, Ana Alonso, Javier Martin, et al.Plos One|April 16, 2014
Selected ABCB1, ABCB4 and ABCC2 polymorphisms do not enhance the risk of drug-induced hepatotoxicity in a Spanish cohortEugenia Ulzurrun, Camilla Stephens, Francisco Ruiz-Cabello, et al.International Journal of Molecular Sciences|July 9, 2022
Major Histocompatibility Complex Class I Chain-Related α (MICA) STR Polymorphisms in COVID-19 PatientsJuan Francisco Gutiérrez-Bautista, Alba Martinez-Chamorro, Antonio Rodriguez-Nicolas, et al.Oncotarget|October 1, 2016
Progressive changes in composition of lymphocytes in lung tissues from patients with non-small-cell lung cancerMaría Del Mar Valenzuela-Membrives, Francisco Perea-García, Abel Sanchez-Palencia, et al.Cancer Immunology, Immunotherapy : CII|December 14, 2004
High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosityTeresa Rodriguez, Rosa Méndez, Chrissy H Roberts, et al.Haematologica|February 3, 2004
Incidence and characteristics of CD4(+)/HLA DRhi dendritic cell malignanciesClara Bueno, Julia Almeida, Paulo Lucio, et al.Pageof 9